Pathogen‐reduced platelets vs standard platelets
Number of participants with a serious adverse event · thrombocytopenia
Pathogen‐reduced platelets showed no clear difference in number of participants with a serious adverse event compared with standard platelets (moderate certainty).
1 finding from 1 review
- RR 1.09 [0.88, 1.35]7 studies · 1340 participantsModerate